Asset

ALISKIREN HEMIFUMARATE

Novartis AG Common Stock

Revenue

No revenue reported in loaded filings.

Clinical trials (0)

No records yet.

FDA applications (3)

ApplicationTypeApplicant
NDA 022217NDANOVARTIS PHARMACEUTICALS CORP
NDA 022545NDANOVARTIS PHARMACEUTICALS CORP
NDA 200045NDANOVARTIS PHARMACEUTICALS CORP

Marketed products (11)

  • AMTURNIDE
  • AMTURNIDE
  • AMTURNIDE
  • AMTURNIDE
  • AMTURNIDE
  • TEKAMLO
  • TEKAMLO
  • TEKAMLO
  • TEKAMLO
  • VALTURNA
  • VALTURNA